alexa Design Of Multivalent Ligand For The Detection And Treatment Of Disease
ISSN: 2161-0444

Medicinal Chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing
December 08-10, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Victor J Hruby
ScientificTracks Abstracts: Med Chem
DOI: 10.4172/2161-0444.S1.011
Abstract
Many of our most prevalent degenerative diseases such as cancer, diabetes, prolonged and neuropathic pain etc. results from multiple changes in our expressed genome. We and others have suggested that for the detection and treatment of these diseases multivalent ligands can provide distinct advantages over monovalent drugs that are the mainstay of most current therapies. Advantages such as enhanced efficacy and synergy and reduction in toxicities can be expected. The design of such ligands requires careful consideration of the three dimensional organization of the multiple pharmacophores so that they can independently, and without interference, interact with their particular receptor/acceptor target and retain their individual binding affinities and efficacies at each target. Peptides are ideally suited for this purpose. This approach with two different examples that require different design strategies will be illustrated. In the first case we will design multivalent ligands that have adjacent, spacer, separated or overlapping pharmacophores and agonist and antagonist activities for the different pharmacophores for the treatment of prolonged and neuropathic pain but without the development of tolerance, addiction, or other toxic side effect of current clinical drugs for prolonged and neuropathic pain. In the second example we will develop novel scaffolds for the design of hetero- and homo- valent ligands for the detection and treatment of cancer. In this approach the pharmacophores must be arranged in 3D space so that they cross-link receptors/acceptors on the cell surface. The synergies obtained can be substantial (102 to 103). It will also be demonstrated that tremendous kinetic advantages can be obtain for cancer detection using this approach.
Biography
Regents Professor Victor J. Hruby received his PhD from Cornell University and did his Postdoctoral Studies at Cornell University Medical Center with Nobel Laureate Vincent du Vigneaud. Currently, he is a Regents Professor at the University of Arizona with appointments in four other departments and programs. He has over 1, 200 publications, serves on the editorial boards of numerous journals, and has been a member of several NIH Study Sections. His major research interests are in the chemical biology, conformation-bioactivity relationships, drug design, molecular mechanisms of information transduction of peptide hormones and neurotransmitters and their ligands that modulate health and disease. He has won numerous awards for his accomplishments including most recently the ACS Ralph F. Hirschmann Award, the ACS Arthur C. Cope Scholar Award, and the APS Murray Goodman Award.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords